The Park Rx trial to increase physical activity among low-income youth.
The Park Rx trial to increase physical activity among low-income youth.
复制标题
DOI:
10.1016/j.cct.2022.106930
复制
发表时间:
2022-11
影响因子:
2.2
通讯作者:
Cohen, Deborah A.
中科院分区:
文献类型:
--
作者:
Zarr, Robert;Han, Bing;Estrada, Erika;Cohen, Deborah A.
The Park Rx study is a prospective, randomized controlled trial implemented within a federally qualified health center serving a low-income population in Washington, DC. The 5-year randomized controlled trial will recruit 500 children, ages 6–16 to be randomized to receive either a park prescription (Park Rx) during routine clinical visits (intervention arm) or care as usual (control arm). Park prescriptions promote both physical activity and exposure to nature. The prescription includes a place (i.e., park), an activity, a frequency, and a duration. Compared to usual care, we expect children receiving a park prescription will have greater physical activity levels and improved physical and mental health outcomes. The results of the Park Rx trial will demonstrate the efficacy of the intervention and whether it will increase time spent in nature-rich areas (i.e., parks); have any biological impacts on health, including reducing hypercholesterolemia, hypertriglyceridemia, HbA1c, body mass index (BMI), and impact mental health, including stress and cognitive functioning. ClinicalTrials.gov identifier: NCT04114734. Registered on October 3, 2019.
登录
查看更多内容
DOI:
10.3390/ijerph110303453
发表时间:
2014-03-21
影响因子:
--
作者:
Beyer KM;Kaltenbach A;Szabo A;Bogar S;Nieto FJ;Malecki KM
通讯作者:
Malecki KM
影响因子:
5
作者:
COHEN, S;KAMARCK, T;MERMELSTEIN, R
通讯作者:
MERMELSTEIN, R
影响因子:
3.7
作者:
Chinapaw MJ;de Niet M;Verloigne M;De Bourdeaudhuij I;Brug J;Altenburg TM
通讯作者:
Altenburg TM
影响因子:
5.4
作者:
Francis, Jacinta;Wood, Lisa J.;Giles-Corti, Billie
通讯作者:
Giles-Corti, Billie
DOI:
10.1186/1479-5868-9-89
发表时间:
2012-07-30
影响因子:
8.7
作者:
Kerr, Jacqueline;Sallis, James F.;King, Abby C.
通讯作者:
King, Abby C.